Global Flow Cytometers

Flow Cytometers Comprehensive Study by Application (Oncology, Drug Discovery, Disease Diagnosis, Stem Cell Therapy, Organ Transplantation, Hematology), Technology (Cell-based, Bead-based), End use (Hospitals and Clinics, Academia and Research Institutes, Pharmaceutical and Biotechnology Companies) Players and Region - Global Market Outlook to 2028

Flow Cytometers Market by XX Submarkets | Forecast Years 2023-2028  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Flow Cytometers Market Scope
A flow cytometer detects the characteristics of the population of cells or particles such as cell size, count, and cycle. The expression of surface and intracellular molecules is analyzed by this method. The flow cytometer provides specific information about the cells. Further, it uses light to count the cells and profile them in a fluid mixture. Also, a series of sensors are used to detect the light which is refracted from the cells. Then, the data acquired is compiled and used to build an image. The increasing usage of flow Cytometry for clinical laboratories is creating a demand for flow cytometers.

AttributesDetails
Study Period2018-2028
Base Year2022
UnitValue (USD Million)
Key Companies ProfiledBecton Dickinson (United States), Beckman Coulter (United States), Merck KGaA (Germany), Partec GMBH (Germany), Thermo Fisher (United States), Luminex Corp (United States), Miltenyi Biotec (Germany), Intellicyt Corp (United States), Sony (Japan) and Apogee Flow Systems (United Kingdom)
CAGR%


Global Flow Cytometers is a fragmented market due to the presence of various players. The players are focusing on investing more in Launching Products. These will enhance their market presence. The companies are also planning strategic activities like partnerships, mergers, and acquisitions which will help them to sustain in the market and maintain their competitive edge. Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global Flow Cytometers market throughout the predicted period.

Becton Dickinson (United States), Beckman Coulter (United States), Merck KGaA (Germany), Partec GMBH (Germany), Thermo Fisher (United States), Luminex Corp (United States), Miltenyi Biotec (Germany), Intellicyt Corp (United States), Sony (Japan) and Apogee Flow Systems (United Kingdom) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are Advanced Analytical (United States), GE Healthcare (United States) and Union Biometrica (United States).

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from the total available market.

Segmentation Overview
The study have segmented the market of Global Flow Cytometers market by Type , by Application (Oncology, Drug Discovery, Disease Diagnosis, Stem Cell Therapy, Organ Transplantation and Hematology) and Region with country level break-up.

On the basis of geography, the market of Flow Cytometers has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). region held largest market share in the year 2022.

Market Leaders and their expansionary development strategies
On 1st February 2022, BD acquired Cytognos. The acquisition helps to enhance BD's strategy to support chronic disease management by expanding its portfolio of blood cancer diagnostics, immune assessment tests, and informatics to address patient, clinician, and care provider needs to better understand the immune system, immune response, and MRD.
On 7th July 2021, BD announced the commercial release of a new bdbiosciences.com web and eCommerce site. The new BD Biosciences website offers a full array of BD research, clinical, and single-cell multi-omic products, making this online destination one of the most comprehensive for flow cytometry users.
Next to the standard parameters that need to be addressed for other immunoassays such as an ELISA, performing flow cytometry in a regulated environment requires additional attention for some specific (flow-related) items. Since in flow cytometry, accuracy cannot be determined, additional attention should be given to the precision of the flow method, precision between multiple operators in method performance, and also in the data processing. (in other words: make sure that multiple operators end up with the same end results when processing samples and processing acquired data). The use of QCs for run acceptance control and method performance monitoring is essential.

Influencing Trend:
Adoption of Flow Cytometer for Research and Development and Increasing Awareness for Cell-Based Assays

Market Growth Drivers:
Rising Clinical Trials is Fueling the Market Growth and Increasing Need for Faster and Accurate Cancer Prognostic Tools

Challenges:
Lack of Awareness among the End Users

Restraints:
High Costs of Equipment in Developing Economies

Opportunities:
Government Initiatives for the Research and Development of Health Care and Rising Biotechnology Sector

Key Target Audience
Manufacturers, Raw Material Suppliers, Distributors and Traders, Research Organisations, Government Agencies and Organizations

Report Objectives / Segmentation Covered

By Application
  • Oncology
  • Drug Discovery
  • Disease Diagnosis
  • Stem Cell Therapy
  • Organ Transplantation
  • Hematology
By Technology
  • Cell-based
  • Bead-based

By End use
  • Hospitals and Clinics
  • Academia and Research Institutes
  • Pharmaceutical and Biotechnology Companies

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rising Clinical Trials is Fueling the Market Growth
      • 3.2.2. Increasing Need for Faster and Accurate Cancer Prognostic Tools
    • 3.3. Market Challenges
      • 3.3.1. Lack of Awareness among the End Users
    • 3.4. Market Trends
      • 3.4.1. Adoption of Flow Cytometer for Research and Development
      • 3.4.2. Increasing Awareness for Cell-Based Assays
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Flow Cytometers, by Application, Technology, End use and Region (value and price ) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Flow Cytometers (Value)
      • 5.2.1. Global Flow Cytometers by: Application (Value)
        • 5.2.1.1. Oncology
        • 5.2.1.2. Drug Discovery
        • 5.2.1.3. Disease Diagnosis
        • 5.2.1.4. Stem Cell Therapy
        • 5.2.1.5. Organ Transplantation
        • 5.2.1.6. Hematology
      • 5.2.2. Global Flow Cytometers by: Technology (Value)
        • 5.2.2.1. Cell-based
        • 5.2.2.2. Bead-based
      • 5.2.3. Global Flow Cytometers by: End use (Value)
        • 5.2.3.1. Hospitals and Clinics
        • 5.2.3.2. Academia and Research Institutes
        • 5.2.3.3. Pharmaceutical and Biotechnology Companies
      • 5.2.4. Global Flow Cytometers Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Australia
          • 5.2.4.2.6. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Flow Cytometers (Price)
  • 6. Flow Cytometers: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Becton Dickinson (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Beckman Coulter (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Merck KGaA (Germany)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Partec GMBH (Germany)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Thermo Fisher (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Luminex Corp (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Miltenyi Biotec (Germany)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Intellicyt Corp (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Sony (Japan)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Apogee Flow Systems (United Kingdom)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Flow Cytometers Sale, by Application, Technology, End use and Region (value and price ) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Flow Cytometers (Value)
      • 7.2.1. Global Flow Cytometers by: Application (Value)
        • 7.2.1.1. Oncology
        • 7.2.1.2. Drug Discovery
        • 7.2.1.3. Disease Diagnosis
        • 7.2.1.4. Stem Cell Therapy
        • 7.2.1.5. Organ Transplantation
        • 7.2.1.6. Hematology
      • 7.2.2. Global Flow Cytometers by: Technology (Value)
        • 7.2.2.1. Cell-based
        • 7.2.2.2. Bead-based
      • 7.2.3. Global Flow Cytometers by: End use (Value)
        • 7.2.3.1. Hospitals and Clinics
        • 7.2.3.2. Academia and Research Institutes
        • 7.2.3.3. Pharmaceutical and Biotechnology Companies
      • 7.2.4. Global Flow Cytometers Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Australia
          • 7.2.4.2.6. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Flow Cytometers (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Flow Cytometers: by Application(USD Million)
  • Table 2. Flow Cytometers Oncology , by Region USD Million (2017-2022)
  • Table 3. Flow Cytometers Drug Discovery , by Region USD Million (2017-2022)
  • Table 4. Flow Cytometers Disease Diagnosis , by Region USD Million (2017-2022)
  • Table 5. Flow Cytometers Stem Cell Therapy , by Region USD Million (2017-2022)
  • Table 6. Flow Cytometers Organ Transplantation , by Region USD Million (2017-2022)
  • Table 7. Flow Cytometers Hematology , by Region USD Million (2017-2022)
  • Table 8. Flow Cytometers: by Technology(USD Million)
  • Table 9. Flow Cytometers Cell-based , by Region USD Million (2017-2022)
  • Table 10. Flow Cytometers Bead-based , by Region USD Million (2017-2022)
  • Table 11. Flow Cytometers: by End use(USD Million)
  • Table 12. Flow Cytometers Hospitals and Clinics , by Region USD Million (2017-2022)
  • Table 13. Flow Cytometers Academia and Research Institutes , by Region USD Million (2017-2022)
  • Table 14. Flow Cytometers Pharmaceutical and Biotechnology Companies , by Region USD Million (2017-2022)
  • Table 15. South America Flow Cytometers, by Country USD Million (2017-2022)
  • Table 16. South America Flow Cytometers, by Application USD Million (2017-2022)
  • Table 17. South America Flow Cytometers, by Technology USD Million (2017-2022)
  • Table 18. South America Flow Cytometers, by End use USD Million (2017-2022)
  • Table 19. Brazil Flow Cytometers, by Application USD Million (2017-2022)
  • Table 20. Brazil Flow Cytometers, by Technology USD Million (2017-2022)
  • Table 21. Brazil Flow Cytometers, by End use USD Million (2017-2022)
  • Table 22. Argentina Flow Cytometers, by Application USD Million (2017-2022)
  • Table 23. Argentina Flow Cytometers, by Technology USD Million (2017-2022)
  • Table 24. Argentina Flow Cytometers, by End use USD Million (2017-2022)
  • Table 25. Rest of South America Flow Cytometers, by Application USD Million (2017-2022)
  • Table 26. Rest of South America Flow Cytometers, by Technology USD Million (2017-2022)
  • Table 27. Rest of South America Flow Cytometers, by End use USD Million (2017-2022)
  • Table 28. Asia Pacific Flow Cytometers, by Country USD Million (2017-2022)
  • Table 29. Asia Pacific Flow Cytometers, by Application USD Million (2017-2022)
  • Table 30. Asia Pacific Flow Cytometers, by Technology USD Million (2017-2022)
  • Table 31. Asia Pacific Flow Cytometers, by End use USD Million (2017-2022)
  • Table 32. China Flow Cytometers, by Application USD Million (2017-2022)
  • Table 33. China Flow Cytometers, by Technology USD Million (2017-2022)
  • Table 34. China Flow Cytometers, by End use USD Million (2017-2022)
  • Table 35. Japan Flow Cytometers, by Application USD Million (2017-2022)
  • Table 36. Japan Flow Cytometers, by Technology USD Million (2017-2022)
  • Table 37. Japan Flow Cytometers, by End use USD Million (2017-2022)
  • Table 38. India Flow Cytometers, by Application USD Million (2017-2022)
  • Table 39. India Flow Cytometers, by Technology USD Million (2017-2022)
  • Table 40. India Flow Cytometers, by End use USD Million (2017-2022)
  • Table 41. South Korea Flow Cytometers, by Application USD Million (2017-2022)
  • Table 42. South Korea Flow Cytometers, by Technology USD Million (2017-2022)
  • Table 43. South Korea Flow Cytometers, by End use USD Million (2017-2022)
  • Table 44. Australia Flow Cytometers, by Application USD Million (2017-2022)
  • Table 45. Australia Flow Cytometers, by Technology USD Million (2017-2022)
  • Table 46. Australia Flow Cytometers, by End use USD Million (2017-2022)
  • Table 47. Rest of Asia-Pacific Flow Cytometers, by Application USD Million (2017-2022)
  • Table 48. Rest of Asia-Pacific Flow Cytometers, by Technology USD Million (2017-2022)
  • Table 49. Rest of Asia-Pacific Flow Cytometers, by End use USD Million (2017-2022)
  • Table 50. Europe Flow Cytometers, by Country USD Million (2017-2022)
  • Table 51. Europe Flow Cytometers, by Application USD Million (2017-2022)
  • Table 52. Europe Flow Cytometers, by Technology USD Million (2017-2022)
  • Table 53. Europe Flow Cytometers, by End use USD Million (2017-2022)
  • Table 54. Germany Flow Cytometers, by Application USD Million (2017-2022)
  • Table 55. Germany Flow Cytometers, by Technology USD Million (2017-2022)
  • Table 56. Germany Flow Cytometers, by End use USD Million (2017-2022)
  • Table 57. France Flow Cytometers, by Application USD Million (2017-2022)
  • Table 58. France Flow Cytometers, by Technology USD Million (2017-2022)
  • Table 59. France Flow Cytometers, by End use USD Million (2017-2022)
  • Table 60. Italy Flow Cytometers, by Application USD Million (2017-2022)
  • Table 61. Italy Flow Cytometers, by Technology USD Million (2017-2022)
  • Table 62. Italy Flow Cytometers, by End use USD Million (2017-2022)
  • Table 63. United Kingdom Flow Cytometers, by Application USD Million (2017-2022)
  • Table 64. United Kingdom Flow Cytometers, by Technology USD Million (2017-2022)
  • Table 65. United Kingdom Flow Cytometers, by End use USD Million (2017-2022)
  • Table 66. Netherlands Flow Cytometers, by Application USD Million (2017-2022)
  • Table 67. Netherlands Flow Cytometers, by Technology USD Million (2017-2022)
  • Table 68. Netherlands Flow Cytometers, by End use USD Million (2017-2022)
  • Table 69. Rest of Europe Flow Cytometers, by Application USD Million (2017-2022)
  • Table 70. Rest of Europe Flow Cytometers, by Technology USD Million (2017-2022)
  • Table 71. Rest of Europe Flow Cytometers, by End use USD Million (2017-2022)
  • Table 72. MEA Flow Cytometers, by Country USD Million (2017-2022)
  • Table 73. MEA Flow Cytometers, by Application USD Million (2017-2022)
  • Table 74. MEA Flow Cytometers, by Technology USD Million (2017-2022)
  • Table 75. MEA Flow Cytometers, by End use USD Million (2017-2022)
  • Table 76. Middle East Flow Cytometers, by Application USD Million (2017-2022)
  • Table 77. Middle East Flow Cytometers, by Technology USD Million (2017-2022)
  • Table 78. Middle East Flow Cytometers, by End use USD Million (2017-2022)
  • Table 79. Africa Flow Cytometers, by Application USD Million (2017-2022)
  • Table 80. Africa Flow Cytometers, by Technology USD Million (2017-2022)
  • Table 81. Africa Flow Cytometers, by End use USD Million (2017-2022)
  • Table 82. North America Flow Cytometers, by Country USD Million (2017-2022)
  • Table 83. North America Flow Cytometers, by Application USD Million (2017-2022)
  • Table 84. North America Flow Cytometers, by Technology USD Million (2017-2022)
  • Table 85. North America Flow Cytometers, by End use USD Million (2017-2022)
  • Table 86. United States Flow Cytometers, by Application USD Million (2017-2022)
  • Table 87. United States Flow Cytometers, by Technology USD Million (2017-2022)
  • Table 88. United States Flow Cytometers, by End use USD Million (2017-2022)
  • Table 89. Canada Flow Cytometers, by Application USD Million (2017-2022)
  • Table 90. Canada Flow Cytometers, by Technology USD Million (2017-2022)
  • Table 91. Canada Flow Cytometers, by End use USD Million (2017-2022)
  • Table 92. Mexico Flow Cytometers, by Application USD Million (2017-2022)
  • Table 93. Mexico Flow Cytometers, by Technology USD Million (2017-2022)
  • Table 94. Mexico Flow Cytometers, by End use USD Million (2017-2022)
  • Table 95. Company Basic Information, Sales Area and Its Competitors
  • Table 96. Company Basic Information, Sales Area and Its Competitors
  • Table 97. Company Basic Information, Sales Area and Its Competitors
  • Table 98. Company Basic Information, Sales Area and Its Competitors
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Flow Cytometers: by Application(USD Million)
  • Table 106. Flow Cytometers Oncology , by Region USD Million (2023-2028)
  • Table 107. Flow Cytometers Drug Discovery , by Region USD Million (2023-2028)
  • Table 108. Flow Cytometers Disease Diagnosis , by Region USD Million (2023-2028)
  • Table 109. Flow Cytometers Stem Cell Therapy , by Region USD Million (2023-2028)
  • Table 110. Flow Cytometers Organ Transplantation , by Region USD Million (2023-2028)
  • Table 111. Flow Cytometers Hematology , by Region USD Million (2023-2028)
  • Table 112. Flow Cytometers: by Technology(USD Million)
  • Table 113. Flow Cytometers Cell-based , by Region USD Million (2023-2028)
  • Table 114. Flow Cytometers Bead-based , by Region USD Million (2023-2028)
  • Table 115. Flow Cytometers: by End use(USD Million)
  • Table 116. Flow Cytometers Hospitals and Clinics , by Region USD Million (2023-2028)
  • Table 117. Flow Cytometers Academia and Research Institutes , by Region USD Million (2023-2028)
  • Table 118. Flow Cytometers Pharmaceutical and Biotechnology Companies , by Region USD Million (2023-2028)
  • Table 119. South America Flow Cytometers, by Country USD Million (2023-2028)
  • Table 120. South America Flow Cytometers, by Application USD Million (2023-2028)
  • Table 121. South America Flow Cytometers, by Technology USD Million (2023-2028)
  • Table 122. South America Flow Cytometers, by End use USD Million (2023-2028)
  • Table 123. Brazil Flow Cytometers, by Application USD Million (2023-2028)
  • Table 124. Brazil Flow Cytometers, by Technology USD Million (2023-2028)
  • Table 125. Brazil Flow Cytometers, by End use USD Million (2023-2028)
  • Table 126. Argentina Flow Cytometers, by Application USD Million (2023-2028)
  • Table 127. Argentina Flow Cytometers, by Technology USD Million (2023-2028)
  • Table 128. Argentina Flow Cytometers, by End use USD Million (2023-2028)
  • Table 129. Rest of South America Flow Cytometers, by Application USD Million (2023-2028)
  • Table 130. Rest of South America Flow Cytometers, by Technology USD Million (2023-2028)
  • Table 131. Rest of South America Flow Cytometers, by End use USD Million (2023-2028)
  • Table 132. Asia Pacific Flow Cytometers, by Country USD Million (2023-2028)
  • Table 133. Asia Pacific Flow Cytometers, by Application USD Million (2023-2028)
  • Table 134. Asia Pacific Flow Cytometers, by Technology USD Million (2023-2028)
  • Table 135. Asia Pacific Flow Cytometers, by End use USD Million (2023-2028)
  • Table 136. China Flow Cytometers, by Application USD Million (2023-2028)
  • Table 137. China Flow Cytometers, by Technology USD Million (2023-2028)
  • Table 138. China Flow Cytometers, by End use USD Million (2023-2028)
  • Table 139. Japan Flow Cytometers, by Application USD Million (2023-2028)
  • Table 140. Japan Flow Cytometers, by Technology USD Million (2023-2028)
  • Table 141. Japan Flow Cytometers, by End use USD Million (2023-2028)
  • Table 142. India Flow Cytometers, by Application USD Million (2023-2028)
  • Table 143. India Flow Cytometers, by Technology USD Million (2023-2028)
  • Table 144. India Flow Cytometers, by End use USD Million (2023-2028)
  • Table 145. South Korea Flow Cytometers, by Application USD Million (2023-2028)
  • Table 146. South Korea Flow Cytometers, by Technology USD Million (2023-2028)
  • Table 147. South Korea Flow Cytometers, by End use USD Million (2023-2028)
  • Table 148. Australia Flow Cytometers, by Application USD Million (2023-2028)
  • Table 149. Australia Flow Cytometers, by Technology USD Million (2023-2028)
  • Table 150. Australia Flow Cytometers, by End use USD Million (2023-2028)
  • Table 151. Rest of Asia-Pacific Flow Cytometers, by Application USD Million (2023-2028)
  • Table 152. Rest of Asia-Pacific Flow Cytometers, by Technology USD Million (2023-2028)
  • Table 153. Rest of Asia-Pacific Flow Cytometers, by End use USD Million (2023-2028)
  • Table 154. Europe Flow Cytometers, by Country USD Million (2023-2028)
  • Table 155. Europe Flow Cytometers, by Application USD Million (2023-2028)
  • Table 156. Europe Flow Cytometers, by Technology USD Million (2023-2028)
  • Table 157. Europe Flow Cytometers, by End use USD Million (2023-2028)
  • Table 158. Germany Flow Cytometers, by Application USD Million (2023-2028)
  • Table 159. Germany Flow Cytometers, by Technology USD Million (2023-2028)
  • Table 160. Germany Flow Cytometers, by End use USD Million (2023-2028)
  • Table 161. France Flow Cytometers, by Application USD Million (2023-2028)
  • Table 162. France Flow Cytometers, by Technology USD Million (2023-2028)
  • Table 163. France Flow Cytometers, by End use USD Million (2023-2028)
  • Table 164. Italy Flow Cytometers, by Application USD Million (2023-2028)
  • Table 165. Italy Flow Cytometers, by Technology USD Million (2023-2028)
  • Table 166. Italy Flow Cytometers, by End use USD Million (2023-2028)
  • Table 167. United Kingdom Flow Cytometers, by Application USD Million (2023-2028)
  • Table 168. United Kingdom Flow Cytometers, by Technology USD Million (2023-2028)
  • Table 169. United Kingdom Flow Cytometers, by End use USD Million (2023-2028)
  • Table 170. Netherlands Flow Cytometers, by Application USD Million (2023-2028)
  • Table 171. Netherlands Flow Cytometers, by Technology USD Million (2023-2028)
  • Table 172. Netherlands Flow Cytometers, by End use USD Million (2023-2028)
  • Table 173. Rest of Europe Flow Cytometers, by Application USD Million (2023-2028)
  • Table 174. Rest of Europe Flow Cytometers, by Technology USD Million (2023-2028)
  • Table 175. Rest of Europe Flow Cytometers, by End use USD Million (2023-2028)
  • Table 176. MEA Flow Cytometers, by Country USD Million (2023-2028)
  • Table 177. MEA Flow Cytometers, by Application USD Million (2023-2028)
  • Table 178. MEA Flow Cytometers, by Technology USD Million (2023-2028)
  • Table 179. MEA Flow Cytometers, by End use USD Million (2023-2028)
  • Table 180. Middle East Flow Cytometers, by Application USD Million (2023-2028)
  • Table 181. Middle East Flow Cytometers, by Technology USD Million (2023-2028)
  • Table 182. Middle East Flow Cytometers, by End use USD Million (2023-2028)
  • Table 183. Africa Flow Cytometers, by Application USD Million (2023-2028)
  • Table 184. Africa Flow Cytometers, by Technology USD Million (2023-2028)
  • Table 185. Africa Flow Cytometers, by End use USD Million (2023-2028)
  • Table 186. North America Flow Cytometers, by Country USD Million (2023-2028)
  • Table 187. North America Flow Cytometers, by Application USD Million (2023-2028)
  • Table 188. North America Flow Cytometers, by Technology USD Million (2023-2028)
  • Table 189. North America Flow Cytometers, by End use USD Million (2023-2028)
  • Table 190. United States Flow Cytometers, by Application USD Million (2023-2028)
  • Table 191. United States Flow Cytometers, by Technology USD Million (2023-2028)
  • Table 192. United States Flow Cytometers, by End use USD Million (2023-2028)
  • Table 193. Canada Flow Cytometers, by Application USD Million (2023-2028)
  • Table 194. Canada Flow Cytometers, by Technology USD Million (2023-2028)
  • Table 195. Canada Flow Cytometers, by End use USD Million (2023-2028)
  • Table 196. Mexico Flow Cytometers, by Application USD Million (2023-2028)
  • Table 197. Mexico Flow Cytometers, by Technology USD Million (2023-2028)
  • Table 198. Mexico Flow Cytometers, by End use USD Million (2023-2028)
  • Table 199. Research Programs/Design for This Report
  • Table 200. Key Data Information from Secondary Sources
  • Table 201. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Flow Cytometers: by Application USD Million (2017-2022)
  • Figure 5. Global Flow Cytometers: by Technology USD Million (2017-2022)
  • Figure 6. Global Flow Cytometers: by End use USD Million (2017-2022)
  • Figure 7. South America Flow Cytometers Share (%), by Country
  • Figure 8. Asia Pacific Flow Cytometers Share (%), by Country
  • Figure 9. Europe Flow Cytometers Share (%), by Country
  • Figure 10. MEA Flow Cytometers Share (%), by Country
  • Figure 11. North America Flow Cytometers Share (%), by Country
  • Figure 12. Global Flow Cytometers share by Players 2022 (%)
  • Figure 13. Global Flow Cytometers share by Players (Top 3) 2022(%)
  • Figure 14. Global Flow Cytometers share by Players (Top 5) 2022(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Becton Dickinson (United States) Revenue, Net Income and Gross profit
  • Figure 17. Becton Dickinson (United States) Revenue: by Geography 2022
  • Figure 18. Beckman Coulter (United States) Revenue, Net Income and Gross profit
  • Figure 19. Beckman Coulter (United States) Revenue: by Geography 2022
  • Figure 20. Merck KGaA (Germany) Revenue, Net Income and Gross profit
  • Figure 21. Merck KGaA (Germany) Revenue: by Geography 2022
  • Figure 22. Partec GMBH (Germany) Revenue, Net Income and Gross profit
  • Figure 23. Partec GMBH (Germany) Revenue: by Geography 2022
  • Figure 24. Thermo Fisher (United States) Revenue, Net Income and Gross profit
  • Figure 25. Thermo Fisher (United States) Revenue: by Geography 2022
  • Figure 26. Luminex Corp (United States) Revenue, Net Income and Gross profit
  • Figure 27. Luminex Corp (United States) Revenue: by Geography 2022
  • Figure 28. Miltenyi Biotec (Germany) Revenue, Net Income and Gross profit
  • Figure 29. Miltenyi Biotec (Germany) Revenue: by Geography 2022
  • Figure 30. Intellicyt Corp (United States) Revenue, Net Income and Gross profit
  • Figure 31. Intellicyt Corp (United States) Revenue: by Geography 2022
  • Figure 32. Sony (Japan) Revenue, Net Income and Gross profit
  • Figure 33. Sony (Japan) Revenue: by Geography 2022
  • Figure 34. Apogee Flow Systems (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 35. Apogee Flow Systems (United Kingdom) Revenue: by Geography 2022
  • Figure 36. Global Flow Cytometers: by Application USD Million (2023-2028)
  • Figure 37. Global Flow Cytometers: by Technology USD Million (2023-2028)
  • Figure 38. Global Flow Cytometers: by End use USD Million (2023-2028)
  • Figure 39. South America Flow Cytometers Share (%), by Country
  • Figure 40. Asia Pacific Flow Cytometers Share (%), by Country
  • Figure 41. Europe Flow Cytometers Share (%), by Country
  • Figure 42. MEA Flow Cytometers Share (%), by Country
  • Figure 43. North America Flow Cytometers Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Becton Dickinson (United States)
  • Beckman Coulter (United States)
  • Merck KGaA (Germany)
  • Partec GMBH (Germany)
  • Thermo Fisher (United States)
  • Luminex Corp (United States)
  • Miltenyi Biotec (Germany)
  • Intellicyt Corp (United States)
  • Sony (Japan)
  • Apogee Flow Systems (United Kingdom)
Additional players considered in the study are as follows:
Advanced Analytical (United States) , GE Healthcare (United States) , Union Biometrica (United States)
Select User Access Type

Key Highlights of Report


May 2023 180 Pages 78 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Flow Cytometers Quantitative research analysis
Global Flow Cytometers Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The key segments that are playing vital role in Flow Cytometers Market are by end use application [Oncology, Drug Discovery, Disease Diagnosis, Stem Cell Therapy, Organ Transplantation and Hematology].
The Flow Cytometers Market is gaining popularity and expected to see strong valuation by 2028.
  • Rising Clinical Trials is Fueling the Market Growth
  • Increasing Need for Faster and Accurate Cancer Prognostic Tools

Know More About Global Flow Cytometers Report?

Have a Query? Click Here

Other Related Reports

Porcine Serum Comprehensive Study by Application (Mycoplasmas and Viruses Culture, Lymphocytes Culture, Vaccine Production, Others), Packaging (100 mL, 500 mL, 1000 mL, Others) Players and Region - G...
$ 3500
Antimicrobial Packaging Comprehensive Study by Type (Pouches, Carton Packages, Bags, Trays, Cups & Lids, Others), Application (Food & Beverages, Personal Care, Healthcare, Others), Antimicrobial Agen...
$ 3650
Podophyllotoxin Comprehensive Study by Type (Purity 95%, Purity 98%, Other), Application (Chemical Reagents, Pharmaceutical Intermediates, Other) Players and Region - Global Market Outlook to 2026
$ 3500
Mitogen Activated Protein Kinase 8 Comprehensive Study by Type (CC-90001, SR-3306, ER-358063, WBZ-4, Others), Application (Breast Cancer, Alzheimer's Disease, Acute Renal Failure, Liver Failure, Othe...
$ 3500
Viral Clearance Service Comprehensive Study by Application (Recombinant Proteins, Blood and Blood Products, Vaccines, Other), End-User (Pharmaceutical & Biotechnology Companies, Contract Research Org...
$ 3650
Trypsin Comprehensive Study by Type (Cationic trypsin or Trypsin-1, Anionic trypsin or Trypsin-2, Mesotrypsin or Trypsin-3), Application (Biological Research, Medicines, Supplements, Others), Form (T...
$ 3450